Targeting signal transduction pathways by chemopreventive agents

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 555, Issue 1-2 SPEC. ISS., 2004, Pages 33-51

  Bode, A M ^a   Dong, Z ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

AP 1; Apoptosis; Caffeine; COX 2; EGCG; Resveratrol

Indexed keywords

3,5,3',4' TETRAHYDROXYSTILBENE; 3,5,3',4',5' PENTAHYDROXYSTILBENE; ANTINEOPLASTIC AGENT; BLACK TEA EXTRACT; CAFFEINE; COLCHICINE; CYCLOOXYGENASE 2; DEHYDROPARADOL; EPICATECHIN; EPIGALLOCATECHIN GALLATE; ETOPOSIDE; GINGER EXTRACT; GINGEROL; GREEN TEA EXTRACT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; METHYLPREDNISOLONE; PACLITAXEL; PARADOL; PHYTIC ACID; PICEATANNOL; RESVERATROL; THEAFLAVIN; THEAFLAVIN 3,3' DIGALLATE; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BREAST CANCER; CANCER CELL; CANCER CONTROL; CANCER INCIDENCE; CARCINOGENESIS; CHEMOPROPHYLAXIS; COLON CARCINOGENESIS; DIETARY INTAKE; DOSE RESPONSE; DRUG ANTAGONISM; DRUG DEVELOPMENT; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; DRUG POTENTIATION; DRUG SAFETY; ESOPHAGUS TUMOR; HUMAN; INTESTINE CANCER; MALIGNANT TRANSFORMATION; NONHUMAN; NUTRITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; SKIN CARCINOGENESIS; SKIN PAPILLOMA; SKIN TUMOR; TEA;

ANIMALS; ANTICARCINOGENIC AGENTS; CHEMOPREVENTION; HUMANS; NEOPLASMS; SIGNAL TRANSDUCTION;

EID: 5144221219     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2004.05.018     Document Type: Review

References (222)

1. M.B. Sporn, and N. Suh Chemoprevention of cancer Carcinogenesis 21 2000 525 530
2. M.B. Sporn, and N. Suh Chemoprevention: an essential approach to controlling cancer Nat. Rev. Cancer 2 2002 537 543
3. M.B. Sporn Carcinogenesis and cancer: different perspectives on the same disease Cancer Res. 51 1991 6215 6218
4. U. Veronesi, G. De Palo, E. Marubini, A. Costa, F. Formelli, L. Mariani, A. Decensi, T. Camerini, M.R. Del Turco, M.G. Di Mauro, M.G. Muraca, M. Del Vecchio, C. Pinto, G. D'Aiuto, C. Boni, T. Campa, A. Magni, R. Miceli, M. Perloff, W.F. Malone, and M.B. Sporn Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer (see comments) J. Natl. Cancer Inst. 91 1999 1847 1856
5. B. Fisher, J.P. Costantino, D.L. Wickerham, C.K. Redmond, M. Kavanah, W.M. Cronin, V. Vogel, A. Robidoux, N. Dimitrov, J. Atkins, M. Daly, S. Wieand, E. Tan-Chiu, L. Ford, and N. Wolmark Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study (see comments) J. Natl. Cancer Inst. 90 1998 1371 1388
6. D. Albanes, O.P. Heinonen, J.K. Huttunen, P.R. Taylor, J. Virtamo, B.K. Edwards, J. Haapakoski, M. Rautalahti, A.M. Hartman, and J. Palmgren Effects of alpha-tocopherol and beta-carotene supplements on cancer incidence in the Alpha-Tocopherol Beta-Carotene Cancer Prevention Study Am. J. Clin. Nutr. 62 1995 1427S 1430S
7. G.S. Omenn, G.E. Goodman, M.D. Thornquist, J. Balmes, M.R. Cullen, A. Glass, J.P. Keogh, F.L. Meyskens, B. Valanis, J.H. Williams, S. Barnhart, and S. Hammar Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease N. Engl. J. Med. 334 1996 1150 1155
8. P.C. Nowell Mechanisms of tumor progression Cancer Res. 46 1986 2203 2207
9. W.K. Hong General keynote: the impact of cancer chemoprevention Gynecol. Oncol. 88 2003 56 58
10. D. Hanahan, and R.A. Weinberg The hallmarks of cancer Cell 100 2000 57 70
11. H.C. Pitot, and Y.P. Dragan The multistage nature of chemically induced hepatocarcinogenesis in the rat Drug Metab. Rev. 26 1994 209 220
12. A.M. Bode, and Z. Dong Signal transduction pathways: targets for chemoprevention of skin cancer Lancet Oncol. 1 2000 181 188
13. A.M. Bode, and Z. Dong Mitogen-activated protein kinase activation in UV-induced signal transduction Sci. STKE 2003 2003 RE2
14. S. Cowley, H. Paterson, P. Kemp, and C.J. Marshall Activation of MAP kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells Cell 77 1994 841 852
15. A. Minden, A. Lin, M. McMahon, C. Lange-Carter, B. Derijard, R.J. Davis, G.L. Johnson, and M. Karin Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MEKK Science 266 1994 1719 1723
16. T. Kallunki, B. Su, I. Tsigelny, H.K. Sluss, B. Derijard, G. Moore, R. Davis, and M. Karin JNK2 contains a specificity-determining region responsible for efficient c-Jun binding and phosphorylation Genes Dev. 8 1994 2996 3007
17. C. Huang, W.Y. Ma, J. Li, and Z. Dong Arsenic induces apoptosis through a c-Jun NH2-terminal kinase-dependent, p53-independent pathway Cancer Res. 59 1999 3053 3058
18. C. Huang, W.Y. Ma, and Z. Dong The extracellular-signal-regulated protein kinases (Erks) are required for UV-induced AP-1 activation in JB6 cells Oncogene 18 1999 2828 2835
19. C. Huang, W.Y. Ma, M.R. Young, N. Colburn, and Z. Dong Shortage of mitogen-activated protein kinase is responsible for resistance to AP-1 transactivation and transformation in mouse JB6 cells Proc. Natl. Acad. Sci. U. S. A. 95 1998 156 161
20. R.G. Watts, C. Huang, M.R. Young, J.J. Li, Z. Dong, W.D. Pennie, and N.H. Colburn Expression of dominant negative Erk2 inhibits AP-1 transactivation and neoplastic transformation Oncogene 17 1998 3493 3498
21. C. Huang, W.Y. Ma, J. Li, A. Goranson, and Z. Dong Requirement of Erk, but not JNK, for arsenite-induced cell transformation J. Biol. Chem. 274 1999 14595 14601
22. C. Huang, J. Li, W.Y. Ma, and Z. Dong JNK activation is required for JB6 cell transformation induced by tumor necrosis factor-alpha but not by 12-O-tetradecanoylphorbol-13-acetate J. Biol. Chem. 274 1999 29672 29676
23. N. Chen, M. Nomura, Q.B. She, W.Y. Ma, A.M. Bode, L. Wang, R.A. Flavell, and Z. Dong Suppression of skin tumorigenesis in c-Jun NH(2)-terminal kinase-2-deficient mice Cancer Res. 61 2001 3908 3912
24. H.C. Pitot, and A.E. Sirica The stages of initiation and promotion in hepatocarcinogenesis Biochim. Biophys. Acta 605 1980 191 215
25. J.F. Kerr, A.H. Wyllie, and A.R. Currie Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics Br. J. Cancer 26 1972 239 257
26. P. Golstein Cell death in us and others Science 281 1998 1283
27. S. Nagata, and P. Golstein The Fas death factor Science 267 1995 1449 1456
28. H. Steller Mechanisms and genes of cellular suicide Science 267 1995 1445 1449
29. C.B. Thompson Apoptosis in the pathogenesis and treatment of disease Science 267 1995 1456 1462
30. M. Barinaga Is apoptosis key in Alzheimer's disease? Science 281 1998 1303 1304
31. M.A. Barry, C.A. Behnke, and A. Eastman Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia Biochem. Pharmacol. 40 1990 2353 2362
32. J.A. Hickman Apoptosis induced by anticancer drugs Cancer Metastasis Rev. 11 1992 121 139
33. S. Sen, and M. D'Incalci Apoptosis: biochemical events and relevance to cancer chemotherapy FEBS Lett. 307 1992 122 127
34. A.J. Merritt, C.S. Potten, C.J. Kemp, J.A. Hickman, A. Balmain, D.P. Lane, and P.A. Hall The role of p53 in spontaneous and radiation-induced apoptosis in the gastrointestinal tract of normal and p53-deficient mice Cancer Res. 54 1994 614 617
35. S.W. Lowe, H.E. Ruley, T. Jacks, and D.E. Housman p53-dependent apoptosis modulates the cytotoxicity of anticancer agents Cell 74 1993 957 967
36. S.A. McCarthy, H.S. Symonds, and T. Van Dyke Regulation of apoptosis in transgenic mice by simian virus 40 T antigen-mediated inactivation of p53 Proc. Natl. Acad. Sci. U. S. A. 91 1994 3979 3983
37. T. Fujiwara, E.A. Grimm, T. Mukhopadhyay, W.W. Zhang, L.B. Owen-Schaub, and J.A. Roth Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wild-type p53 gene Cancer Res. 54 1994 2287 2291
38. A.R. Clarke, S. Gledhill, M.L. Hooper, C.C. Bird, and A.H. Wyllie p53 dependence of early apoptotic and proliferative responses within the mouse intestinal epithelium following gamma-irradiation Oncogene 9 1994 1767 1773
39. D. Malkin, F.P. Li, L.C. Strong, J.F. Fraumeni Jr., C.E. Nelson, D.H. Kim, J. Kassel, M.A. Gryka, F.Z. Bischoff, and M.A. Tainsky Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms Science 250 1990 1233 1238
40. L.A. Donehower, M. Harvey, B.L. Slagle, M.J. McArthur, C.A. Montgomery Jr., J.S. Butel, and A. Bradley Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours Nature 356 1992 215 221
41. C. Prives, and P.A. Hall The p53 pathway J. Pathol. 187 1999 112 126
42. L.D. Tomei, P. Kanter, and C.E. Wenner Inhibition of radiation-induced apoptosis in vitro by tumor promoters Biochem. Biophys. Res. Commun. 155 1988 324 331
43. I.J. Forbes, P.D. Zalewski, C. Giannakis, and P.A. Cowled Induction of apoptosis in chronic lymphocytic leukemia cells and its prevention by phorbol ester Exp. Cell Res. 198 1992 367 372
44. Q. Song, G.D. Baxter, E.M. Kovacs, D. Findik, and M.F. Lavin Inhibition of apoptosis in human tumour cells by okadaic acid J. Cell Physiol. 153 1992 550 556
45. K.P. Bhat, and J.M. Pezzuto Cancer chemopreventive activity of resveratrol Ann. N Y Acad. Sci. 957 2002 210 229
46. J. Gusman, H. Malonne, and G. Atassi A reappraisal of the potential chemopreventive and chemotherapeutic properties of resveratrol Carcinogenesis 22 2001 1111 1117
47. A.M. Bode, and Z. Dong Y. Bao R. Fenwick Phytochemicals in Health and Disease 2004 Marcel Dekker New York 257 284
48. C.S. Yang, J.Y. Chung, G. Yang, S.K. Chhabra, and M.J. Lee Tea and tea polyphenols in cancer prevention J. Nutr. 130 2000 472S 478S
49. J.D. Lambert, and C.S. Yang Mechanisms of cancer prevention by tea constituents J. Nutr. 133 2003 3262S 3267S
50. A.M. Bode, and Z. Dong Signal transduction pathways: targets for green and black tea polyphenols J. Biochem. Mol. Biol. 36 2003 66 77
51. T. Hashimoto, Z. He, W.Y. Ma, P.C. Schmid, A.M. Bode, C.S. Yang, and Z. Dong Caffeine inhibits cell proliferation by G0/G1 phase arrest in JB6 cells Cancer Res. 64 2004 3344 3349
52. Z. He, W.Y. Ma, T. Hashimoto, A.M. Bode, C.S. Yang, and Z. Dong Induction of apoptosis by caffeine is mediated by the p53, Bax, and caspase 3 pathways Cancer Res. 63 2003 4396 4401
53. A.M. Shamsuddin, I. Vucenik, and K.E. Cole IP6: a novel anti-cancer agent Life Sci. 61 1997 343 354
54. I. Vucenik, and A.M. Shamsuddin Cancer inhibition by inositol hexaphosphate (IP6) and inositol: from laboratory to clinic J. Nutr. 133 2003 3778S 3784S
55. A.M. Bode, W.Y. Ma, Y.J. Surh, and Z. Dong Inhibition of epidermal growth factor-induced cell transformation and activator protein 1 activation by [6]-gingerol Cancer Res. 61 2001 850 853
56. W. Dercks, and L.L. Creasy The significance of stilbene phytoalexins in the Plasmopara viticola-grapevine interaction Physiol. Mol. Plant Pathol. 34 1989 189 202
57. W. Dercks, and L.L. Creasy The influence of fosetyl-Al on phytoalexin accumulation in the Plasmopara viticola-grapevine interaction Physiol. Mol. Plant Pathol. 1989 34
58. N. Ahmad, V.M. Adhami, F. Afaq, D.K. Feyes, and H. Mukhtar Resveratrol causes WAF-1/p21-mediated G(1)-phase arrest of cell cycle and induction of apoptosis in human epidermoid carcinoma A431 cells Clin. Cancer Res. 7 2001 1466 1473
59. Y.J. Surh, Y.J. Hurh, J.Y. Kang, E. Lee, G. Kong, and S.J. Lee Resveratrol, an antioxidant present in red wine, induces apoptosis in human promyelocytic leukemia (HL-60) cells Cancer Lett. 140 1999 1 10
60. F. Wolter, B. Akoglu, A. Clausnitzer, and J. Stein Downregulation of the cyclin D1/Cdk4 complex occurs during resveratrol-induced cell cycle arrest in colon cancer cell lines J. Nutr. 131 2001 2197 2203
61. H.B. Zhou, Y. Yan, Y.N. Sun, and J.R. Zhu Resveratrol induces apoptosis in human esophageal carcinoma cells World J. Gastroenterol. 9 2003 408 411
62. Q. Wang, H. Li, X.W. Wang, D.C. Wu, X.Y. Chen, and J. Liu Resveratrol promotes differentiation and induces Fas-independent apoptosis of human medulloblastoma cells Neurosci. Lett. 351 2003 83 86
63. F. Scarlatti, G. Sala, G. Somenzi, P. Signorelli, N. Sacchi, and R. Ghidoni Resveratrol induces growth inhibition and apoptosis in metastatic breast cancer cells via de novo ceramide signaling FASEB J. 17 2003 2339 2341
64. R.M. Niles, M. McFarland, M.B. Weimer, A. Redkar, Y.M. Fu, and G.G. Meadows Resveratrol is a potent inducer of apoptosis in human melanoma cells Cancer Lett. 190 2003 157 163
65. M. Mouria, A.S. Gukovskaya, Y. Jung, P. Buechler, O.J. Hines, H.A. Reber, and S.J. Pandol Food-derived polyphenols inhibit pancreatic cancer growth through mitochondrial cytochrome C release and apoptosis Int. J. Cancer 98 2002 761 769
66. A.K. Joe, H. Liu, M. Suzui, M.E. Vural, D. Xiao, and I.B. Weinstein Resveratrol induces growth inhibition, S-phase arrest, apoptosis, and changes in biomarker expression in several human cancer cell lines Clin. Cancer Res. 8 2002 893 903
67. Y.A. Kim, B.T. Choi, Y.T. Lee, D.I. Park, S.H. Rhee, K.Y. Park, and Y.H. Choi Resveratrol inhibits cell proliferation and induces apoptosis of human breast carcinoma MCF-7 cells Oncol. Rep. 11 2004 441 446
68. H. Ferry-Dumazet, O. Garnier, M. Mamani-Matsuda, J. Vercauteren, F. Belloc, C. Billiard, M. Dupouy, D. Thiolat, J.P. Kolb, G. Marit, J. Reiffers, and M.D. Mossalayi Resveratrol inhibits the growth and induces the apoptosis of both normal and leukemic hematopoietic cells Carcinogenesis 23 2002 1327 1333
69. X. Gao, Y.X. Xu, G. Divine, N. Janakiraman, R.A. Chapman, and S.C. Gautam Disparate in vitro and in vivo antileukemic effects of resveratrol, a natural polyphenolic compound found in grapes J. Nutr. 132 2002 2076 2081
70. Y.A. Kim, W.H. Lee, T.H. Choi, S.H. Rhee, K.Y. Park, and Y.H. Choi Involvement of p21WAF1/CIP1, pRB, Bax and NF-kappaB in induction of growth arrest and apoptosis by resveratrol in human lung carcinoma A549 cells Int. J. Oncol. 2003 23
71. C. Billard, J.C. Izard, V. Roman, C. Kern, C. Mathiot, F. Mentz, and J.P. Kolb Comparative antiproliferative and apoptotic effects of resveratrol, epsilon-viniferin and vine-shots derived polyphenols (vineatrols) on chronic B lymphocytic leukemia cells and normal human lymphocytes Leuk. Lymphoma 43 2002 1991 2002
72. S. Ferry, M. Matsuda, H. Yoshida, and M. Hirata Inositol hexakisphosphate blocks tumor cell growth by activating apoptotic machinery as well as by inhibiting the Akt/NFkappaB-mediated cell survival pathway Carcinogenesis 2002 23
73. M.V. Clement, J.L. Hirpara, S.H. Chawdhury, and S. Pervaiz Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells Blood 92 1998 996 1002
74. A. Shih, F.B. Davis, H.Y. Lin, and P.J. Davis Resveratrol induces apoptosis in thyroid cancer cell lines via a MAPK- and p53-dependent mechanism J. Clin. Endocrinol. Metab. 87 2002 1223 1232
75. S.J. Baek, L.C. Wilson, and T.E. Eling Resveratrol enhances the expression of non-steroidal anti-inflammatory drug-activated gene (NAG-1) by increasing the expression of p53 Carcinogenesis 23 2002 425 434
76. J. Lu, C.H. Ho, G. Ghai, and K.Y. Chen Resveratrol analog, 3,4,5,4′-tetrahydroxystilbene, differentially induces pro-apoptotic p53/Bax gene expression and inhibits the growth of transformed cells but not their normal counterparts Carcinogenesis 22 2001 321 328
77. C. Huang, W.Y. Ma, and Z. Dong Requirement for phosphatidylinositol 3-kinase in epidermal growth factor-induced AP-1 transactivation and transformation in JB6 P+ cells Mol. Cell Biol. 16 1996 6427 6435
78. Z. Dong, M.J. Birrer, R.G. Watts, L.M. Matrisian, and N.H. Colburn Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells Proc. Natl. Acad. Sci. U. S. A. 91 1994 609 613
79. Q.B. She, W.Y. Ma, M. Wang, A. Kaji, C.T. Ho, and Z. Dong Inhibition of cell transformation by resveratrol and its derivatives: differential effects and mechanisms involved Oncogene 22 2003 2143 2150
80. C. Huang, W.Y. Ma, A. Goranson, and Z. Dong Resveratrol suppresses cell transformation and induces apoptosis through a p53-dependent pathway Carcinogenesis 20 1999 237 242
81. Q.B. She, A.M. Bode, W.Y. Ma, N.Y. Chen, and Z. Dong Resveratrol-induced activation of p53 and apoptosis is mediated by extracellular-signal-regulated protein kinases and p38 kinase Cancer Res. 61 2001 1604 1610
82. A.J. Levine p53, the cellular gatekeeper for growth and division Cell 88 1997 323 331
83. M. Mahyar-Roemer, A. Katsen, P. Mestres, and K. Roemer Resveratrol induces colon tumor cell apoptosis independently of p53 and precede by epithelial differentiation, mitochondrial proliferation and membrane potential collapse Int. J. Cancer 94 2001 615 622
84. A.R. Jazirehi, and B. Bonavida Resveratrol modifies the expression of apoptotic regulatory proteins and sensitizes non-Hodgkin's lymphoma and multiple myeloma cell lines to paclitaxel-induced apoptosis Mol. Cancer Ther. 3 2004 71 84
85. T. Kubota, Y. Uemura, M. Kobayashi, and H. Taguchi Combined effects of resveratrol and paclitaxel on lung cancer cells Anticancer Res. 23 2003 4039 4046
86. S. Fulda, and K.M. Debatin Sensitization for tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by the chemopreventive agent resveratrol Cancer Res. 64 2004 337 346
87. G. Nicolini, R. Rigolio, A. Scuteri, M. Miloso, D. Saccomanno, G. Cavaletti, and G. Tredici Effect of trans-resveratrol on signal transduction pathways involved in paclitaxel-induced apoptosis in human neuroblastoma SH-SY5Y cells Neurochem. Int. 42 2003 419 429
88. N. Ahmad, D.K. Feyes, A.L. Nieminen, R. Agarwal, and H. Mukhtar Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells J. Natl. Cancer Inst. 1997 89
89. J. Lu, C.T. Ho, G. Ghai, and K.Y. Chen Differential effects of theaflavin monogallates on cell growth, apoptosis, and Cox-2 gene expression in cancerous versus normal cells Cancer Res. 60 2000 6465 6471
90. N. Ahmad, S. Gupta, and H. Mukhtar Green tea polyphenol epigallocatechin-3-gallate differentially modulates nuclear factor kappaB in cancer cells versus normal cells Arch. Biochem. Biophys. 376 2000 338 346
91. C. Chen, G. Shen, V. Hebbar, R. Hu, E.D. Owuor, and A.N. Kong Epigallocatechin-3-gallate-induced stress signals in HT-29 human colon adenocarcinoma cells Carcinogenesis 24 2003 1369 1378
92. K. Hastak, S. Gupta, N. Ahmad, M.K. Agarwal, M.L. Agarwal, and H. Mukhtar Role of p53 and NF-kappaB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells Oncogene 22 2003 4851 4859
93. P.L. Kuo, and C.C. Lin Green tea constituent (-)-epigallocatechin-3- gallate inhibits Hep G2 cell proliferation and induces apoptosis through p53-dependent and Fas-mediated pathways J. Biomed. Sci. 10 2003 219 227
94. N.Y. Chen, W.Y. Ma, C.S. Yang, and Z. Dong Inhibition of arsenite-induced apoptosis and AP-1 activity by epigallocatechin-3-gallate and theaflavins J. Environ. Pathol. Toxicol. Oncol. 19 2000 287 295
95. J.H. Chung, J.H. Han, E.J. Hwang, J.Y. Seo, K.H. Cho, K.H. Kim, J.I. Youn, and H.C. Eun Dual mechanisms of green tea extract (EGCG)-induced cell survival in human epidermal keratinocytes FASEB J. 17 2003 1913 1915
96. F. Afaq, V.M. Adhami, N. Ahmad, and H. Mukhtar Inhibition of ultraviolet B-mediated activation of nuclear factor kappaB in normal human epidermal keratinocytes by green tea constituent (-)-epigallocatechin-3-gallate Oncogene 2003 22
97. I. Vucenik, V.J. Tomazic, D. Fabian, and A.M. Shamsuddin Antitumor activity of phytic acid (inositol hexaphosphate) in murine transplanted and metastatic fibrosarcoma, a pilot study Cancer Lett. 1992 65
98. T.O. Pretlow, M.A. O'Riorda, and T.G. Pretlow Colon carcinogenesis is inhibited more effectively by phytate than by selenium if F344 rats given 30 mg/kg azoxymethane M.M. Jacobs Diet and Cancer Markers, Prevention and Treatment 1994 Plenum Press New York 244
99. R.D. Estensen, and L.W. Wattenberg Studies of chemopreventive effects of myoinositol on benzo[a]pyrene-induced neoplasia of the lung and forestomach of female A/J mice Carcinogenesis 14 1993 1975 1977
100. D.J. Cosgrove Inositol Phosphates, Their Chemistry, Biochemistry and Physiology 1980 Elsevier Science
101. C.M. Bunce, P.J. French, P. Allen, J.C. Mountford, B. Moor, M.F. Greaves, R.H. Michell, and G. Brown Comparison of the levels of inositol metabolites in transformed haemopoietic cells and their normal counterparts Biochem. J. 289 Pt 3 1993 667 673
102. Y.J. Surh, E. Lee, and J.M. Lee Chemoprotective properties of some pungent ingredients present in red pepper and ginger Mut. Res. 402 1998 259 267
103. K.P. Gupta, J. Singh, and R. Bharathi Suppression of DMBA-induced mouse skin tumor development by inositol hexaphosphate and its mode of action Nutr. Cancer 2003 46
104. R.P. Singh, C. Agarwal, and R. Agarwal Inositol hexaphosphate inhibits growth, and induces G1 arrest and apoptotic death of prostate carcinoma DU145 cells: modulation of CDKI-CDK-cyclin and pRb-related protein-E2F complexes Carcinogenesis 24 2003 555 563
105. R.P. Singh, G. Sharma, G.U. Mallikarjuna, S. Dhanalakshmi, C. Agarwal, and R. Agarwal In vivo suppression of hormone-refractory prostate cancer growth by inositol hexaphosphate: induction of insulin-like growth factor binding protein-3 and inhibition of vascular endothelial growth factor Clin. Cancer Res. 10 2004 244 250
106. G. Sharma, R.P. Singh, and R. Agarwal Growth inhibitory and apoptotic effects of inositol hexaphosphate in transgenic adenocarcinoma of mouse prostate (TRAMP-C1) cells Int. J. Oncol. 23 2003 1413 1418
107. 6) on human normal and leukaemic haematopoietic cells Br. J. Haematol. 117 2002 577 587
108. 6) Anticancer Res. 21 2001 2393 2403
109. I.T. Saied, and A.M. Shamsuddin Up-regulation of the tumor suppressor gene p53 and WAF1 gene expression by IP6 in HT-29 human colon carcinoma cell line Anticancer Res. 18 1998 1479 1484
110. Y. Surh Molecular mechanisms of chemopreventive effects of selected dietary and medicinal phenolic substances Mut. Res. 428 1999 305 327
111. K.L. Grant, and R.B. Lutz Ginger Am. J. Health Syst. Pharm. 57 2000 945 947
112. N. Yoshimi, A. Wang, Y. Morishita, T. Tanaka, S. Sugie, K. Kawai, J. Yamahara, and H. Mori Modifying effects of fungal and herb metabolites on azoxymethane-induced intestinal carcinogenesis in rats Jpn. J. Cancer Res. 83 1992 1273 1278
113. S. Vimala, A.W. Norhanom, and M. Yadav Anti-tumour promoter activity in Malaysian ginger rhizobia used in traditional medicine Br. J. Cancer 80 1999 110 116
114. G.J. Kapadia, M.A. Azuine, H. Tokuda, E. Hang, T. Mukainaka, H. Nishino, and R. Sridhar Inhibitory effect of herbal remedies on 12-O- tetradecanoylphorbol-13-acetate-promoted Epstein-Barr virus early antigen activation Pharmacol. Res. 45 2002 213 220
115. S.K. Katiyar, R. Agarwal, and H. Mukhtar Inhibition of tumor promotion in SENCAR mouse skin by ethanol extract of Zingiber officinale rhizome Cancer Res. 56 1996 1023 1030
116. K.K. Park, K.S. Chun, J.M. Lee, S.S. Lee, and Y.J. Surh Inhibitory effects of [6]-gingerol, a major pungent principle of ginger, on phorbol ester-induced inflammation, epidermal ornithine decarboxylase activity and skin tumor promotion in ICR mice Cancer Lett. 129 1998 139 144
117. W.Y. Chung, Y.J. Jung, Y.J. Surh, S.S. Lee, and K.K. Park Antioxidative and antitumor promoting effects of [6]-paradol and its homologs Mut. Res. 496 2001 199 206
118. U. Thatte, S. Bagadey, and S. Dahanukar Modulation of programmed cell death by medicinal plants Cell Mol. Biol. (Noisy-le-grand) 46 2000 199 214
119. Y.S. Keum, J. Kim, K.H. Lee, K.K. Park, Y.J. Surh, J.M. Lee, S.S. Lee, J.H. Yoon, S.Y. Joo, I.H. Cha, and J.I. Yook Induction of apoptosis and caspase-3 activation by chemopreventive [6]-paradol and structurally related compounds in KB cells Cancer Lett. 177 2002 41 47
120. N. Miyoshi, Y. Nakamura, Y. Ueda, M. Abe, Y. Ozawa, K. Uchida, and T. Osawa Dietary ginger constituents, galanals A and B are potent apoptosis inducers in Human T lymphoma Jurkat cells Cancer Lett. 2003 199
121. P. Angel, and M. Karin The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation Biochim. Biophys. Acta 1072 1991 129 157
122. C. Huang, W.Y. Ma, D. Hanenberger, M.P. Cleary, G.T. Bowden, and Z. Dong Inhibition of ultraviolet B-induced activator protein-1 (AP-1) activity by aspirin in AP-1-luciferase transgenic mice J. Biol. Chem. 272 1997 26325 26331
123. J.J. Li, Z. Dong, M.I. Dawson, and N.H. Colburn Inhibition of tumor promoter-induced transformation by retinoids that transrepress AP-1 without transactivating retinoic acid response element Cancer Res. 56 1996 483 489
124. Z. Dong, S.G. Watts, Y. Sun, and N.H. Colburn Progressive elevation of AP-1 activity during preneoplastic-to neoplastic progression as modeled in mouse JB6 cell variants Int. J. Oncol. 7 1995 359 364
125. T. Deng, and M. Karin JunB differs from c-Jun in its DNA-binding and dimerization domains, and represses c-Jun by formation of inactive heterodimers Genes Dev. 7 1993 479 490
126. R. Chiu, P. Angel, and M. Karin Jun-B differs in its biological properties from, and is a negative regulator of, c-Jun Cell 59 1989 979 986
127. E. Passegue, W. Jochum, M. Schorpp-Kistner, U. Mohle-Steinlein, and E.F. Wagner Chronic myeloid leukemia with increased granulocyte progenitors in mice lacking junB expression in the myeloid lineage Cell 104 2001 21 32
128. R. Zenz, H. Scheuch, P. Martin, C. Frank, R. Eferl, L. Kenner, M. Sibilia, and E.F. Wagner c-Jun regulates eyelid closure and skin tumor development through EGFR signaling Dev. Cell 4 2003 879 889
129. C.M. Pfarr, F. Mechta, G. Spyrou, D. Lallemand, S. Carillo, and M. Yaniv Mouse JunD negatively regulates fibroblast growth and antagonizes transformation by ras Cell 76 1994 747 760
130. P.A. Baeuerle, and D. Baltimore NF-kappa B: ten years after Cell 87 1996 13 20
131. P.A. Baeuerle, and T. Henkel Function and activation of NF-kappa B in the immune system Annu. Rev. Immunol. 12 1994 141 179
132. M. Karin The NF-kappa B activation pathway: its regulation and role in inflammation and cell survival Cancer J. Sci. Am. 4 Suppl 1 1998 92 99
133. M. Karin, and Y. Ben-Neriah Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity Annu. Rev. Immunol. 18 2000 621 663
134. M. Karin, and M. Delhase The I kappa B kinase (IKK) and NF-kappa B: key elements of proinflammatory signalling Semin. Immunol. 12 2000 85 98
135. A.S. Baldwin Jr. The NF-kappa B and I kappa B proteins: new discoveries and insights Annu. Rev. Immunol. 14 1996 649 683
136. K. Schulze-Osthoff, D. Ferrari, K. Riehemann, and S. Wesselborg Regulation of NF-kappa B activation by MAP kinase cascades Immunobiology 198 1997 35 49
137. T.D. Gilmore Clinically relevant findings [editorial] J. Clin. Invest. 100 1997 2935 2936
138. J.J. Li, C. Westergaard, P. Ghosh, and N.H. Colburn Inhibitors of both nuclear factor-kappaB and activator protein-1 activation block the neoplastic transformation response Cancer Res. 57 1997 3569 3576
139. A.A. Beg, W.C. Sha, R.T. Bronson, S. Ghosh, and D. Baltimore Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B Nature 376 1995 167 170
140. C. Abbadie, N. Kabrun, F. Bouali, J. Smardova, D. Stehelin, B. Vandenbunder, and P.J. Enrietto High levels of c-rel expression are associated with programmed cell death in the developing avian embryo and in bone marrow cells in vitro Cell 75 1993 899 912
141. S.R. Coughlin, J.A. Escobedo, and L.T. Williams Role of phosphatidylinositol kinase in PDGF receptor signal transduction Science 243 1989 1191 1194
142. R.C. Stein, and M.D. Waterfield PI3-kinase inhibition: a target for drug development? Mol. Med. Today 6 2000 347 357
143. L.A. Serunian, K.R. Auger, T.M. Roberts, and L.C. Cantley Production of novel polyphosphoinositides in vivo is linked to cell transformation by polyomavirus middle T antigen J. Virol. 64 1990 4718 4725
144. Z. Dong, C. Huang, and W.Y. Ma PI-3 kinase in signal transduction, cell transformation, and as a target for chemoprevention of cancer Anticancer Res. 19 1999 3743 3747
145. C. Huang, W.Y. Ma, S.S. Hecht, and Z. Dong Inositol hexaphosphate inhibits cell transformation and activator protein 1 activation by targeting phosphatidylinositol-3′ kinase Cancer Res. 57 1997 2873 2878 (published erratum appears in Cancer Res. 1997 Nov 15;57(22):5198)
146. E. Pozo-Guisado, M.J. Lorenzo-Benayas, and P.M. Fernandez-Salguero Resveratrol modulates the phosphoinositide 3-kinase pathway through an estrogen receptor alpha-dependent mechanism: relevance in cell proliferation Int. J. Cancer 2004 109
147. S.K. Manna, A. Mukhopadhyay, and B.B. Aggarwal Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation J. Immunol. 164 2000 6509 6519
148. M. Holmes-McNary, and A.S. Baldwin Jr. Chemopreventive properties of trans-resveratrol are associated with inhibition of activation of the IkappaB kinase Cancer Res. 60 2000 3477 3483
149. K. Ashikawa, S. Majumdar, S. Banerjee, A.C. Bharti, S. Shishodia, and B.B. Aggarwal Piceatannol inhibits TNF-induced NF-kappaB activation and NF-kappaB-mediated gene expression through suppression of IkappaBalpha kinase and p65 phosphorylation J. Immunol. 169 2002 6490 6497
150. U.R. Pendurthi, F. Meng, N. Mackman, and L.V. Rao Mechanism of resveratrol-mediated suppression of tissue factor gene expression Thromb. Haemost. 87 2002 155 162
151. V.M. Adhami, F. Afaq, and N. Ahmad Suppression of ultraviolet B exposure-mediated activation of NF-kappaB in normal human keratinocytes by resveratrol Neoplasia 5 2003 74 82
152. S.K. Katiyar, and H. Mukhtar Tea in chemoprevention of cancer: epidemiologic and experimental studies. Int. J. Oncol. 8 1996 221 238
153. I.E. Dreosti, M.J. Wargovich, and C.S. Yang Inhibition of carcinogenesis by tea: the evidence from experimental studies Crit. Rev. Food Sci. Nutr. 37 1997 761 770
154. C.S. Yang, and Z.Y. Wang Tea and cancer J. Natl. Cancer Inst. 85 1993 1038 1049
155. C.S. Yang, G.Y. Yang, M.L. Lee, and L. Chen Mechanistic considerations of the inhibition of carcinogenesis by tea H. Ohigashi Proceedings of the International Conference on Food Factor in Cancer Prevention 1997 Springer-Verlag Tokyo 113 117
156. H.Y. Ahn, K.R. Hadizadeh, C. Seul, Y.P. Yun, H. Vetter, and A. Sachinidis Epigallocathechin-3 gallate selectively inhibits the PDGF-BB-induced intracellular signaling transduction pathway in vascular smooth muscle cells and inhibits transformation of sis-transfected NIH 3T3 fibroblasts and human glioblastoma cells (A172) Mol. Biol. Cell 10 1999 1093 1104
157. Z. Dong, W. Ma, C. Huang, and C.S. Yang Inhibition of tumor promoter-induced activator protein 1 activation and cell transformation by tea polyphenols, (-)-epigallocatechin gallate, and theaflavins Cancer Res. 57 1997 4414 4419
158. J.Y. Chung, C. Huang, X. Meng, Z. Dong, and C.S. Yang Inhibition of activator protein 1 activity and cell growth by purified green tea and black tea polyphenols in H-ras-transformed cells: structure-activity relationship and mechanisms involved Cancer Res. 1999 59
159. J.Y. Chung, J.O. Park, H. Phyu, Z. Dong, and C.S. Yang Mechanisms of inhibition of the Ras-MAP kinase signaling pathway in 30.7b Ras 12 cells by tea polyphenols (-)-epigallocatechin-3-gallate and theaflavin-3,3′-digallate FASEB J. 15 2001 2022 2024
160. M. Barthelman, W. Chen, H.L. Gensler, C. Huang, Z. Dong, and G.T. Bowden Inhibitory effects of perillyl alcohol on UVB-induced murine skin cancer and AP-1 transactivation Cancer Res. 58 1998 711 716
161. M. Barthelman, W.B. Bair 3rd, K.K. Stickland, W. Chen, B.N. Timmermann, S. Valcic, Z. Dong, and G.T. Bowden (-)-Epigallocatechin-3-gallate inhibition of ultraviolet B-induced AP-1 activity Carcinogenesis 19 1998 2201 2204
162. W. Chen, Z. Dong, S. Valcic, B.N. Timmermann, and G.T. Bowden Inhibition of ultraviolet B-induced c-fos gene expression and p38 mitogen-activated protein kinase activation by (-)-epigallocatechin gallate in a human keratinocyte cell line Mol. Carcinog. 24 1999 79 84
163. M. Nomura, W.Y. Ma, C. Huang, C.S. Yang, G.T. Bowden, K. Miyamoto, and Z. Dong Inhibition of ultraviolet B-induced AP-1 activation by theaflavins from black tea Mol. Carcinog. 28 2000 148 155
164. M. Nomura, W. Ma, N. Chen, A.M. Bode, and Z. Dong Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced NF-kappaB activation by tea polyphenols, (-)-epigallocatechin gallate and theaflavins Carcinogenesis 21 2000 1885 1890
165. S. Nam, D.M. Smith, and Q.P. Dou Ester bond-containing tea polyphenols potently inhibit proteasome activity in vitro and in vivo J. Biol. Chem. 276 2001 13322 13330
166. I. Vivanco, and C.L. Sawyers The phosphatidylinositol 3-kinase AKT pathway in human cancer Nat. Rev. Cancer 2 2002 489 501
167. M. Nomura, A. Kaji, Z. He, W.Y. Ma, K. Miyamoto, C.S. Yang, and Z. Dong Inhibitory mechanisms of tea polyphenols on the ultraviolet B-activated phosphatidylinositol 3-kinase-dependent pathway J. Biol. Chem. 276 2001 46624 46631
168. S. Pianetti, S. Guo, K.T. Kavanagh, and G.E. Sonenshein Green tea polyphenol epigallocatechin-3 gallate inhibits Her-2/neu signaling, proliferation, and transformed phenotype of breast cancer cells Cancer Res. 62 2002 652 655
169. C. Huang, P.C. Schmid, W.Y. Ma, H.H. Schmid, and Z. Dong Phosphatidylinositol-3 kinase is necessary for 12-O- tetradecanoylphorbol-13- acetate-induced cell transformation and activated protein 1 activation J. Biol. Chem. 272 1997 4187 4194
170. N. Chen, W.Y. Ma, and Z. Dong Inositol hexaphosphate inhibits ultraviolet B-induced signal transduction Mol. Carcinog. 31 2001 139 144
171. T. Ishikawa, Y. Nakatsuru, M. Zarkovic, and A.M. Shamsuddin Inhibition of skin cancer by IP6 in vivo: initiation-promotion model Anticancer Res. 19 1999 3749 3752
172. C. Agarwal, S. Dhanalakshmi, R.P. Singh, and R. Agarwal Inositol hexaphosphate inhibits constitutive activation of NF-kappa B in androgen-independent human prostate carcinoma DU145 cells Anticancer Res. 23 2003 3855 3861
173. D.S. Goodsell The molecular perspective: cyclooxygenase-2 Stem Cells 18 2000 227 229
174. J.E. Dinchuk, R.Q. Liu, and J.M. Trzaskos COX-3: in the wrong frame in mind Immunol. Lett. 86 2003 121
175. N.V. Chandrasekharan, H. Dai, K.L. Roos, N.K. Evanson, J. Tomsik, T.S. Elton, and D.L. Simmons COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression Proc. Natl. Acad. Sci. U. S. A. 99 2002 13926 13931
176. S.M. Prescott, and F.A. Fitzpatrick Cyclooxygenase-2 and carcinogenesis Biochim. Biophys. Acta 1470 2000 69 78
177. K. Subbaramaiah, and A.J. Dannenberg Cyclooxygenase 2: a molecular target for cancer prevention and treatment Trends Pharmacol. Sci. 24 2003 96 102
178. M.E. Turini, and R.N. DuBois Cyclooxygenase-2: a therapeutic target Annu. Rev. Med. 53 2002 35 57
179. W. Kutchera, D.A. Jones, N. Matsunami, J. Groden, T.M. McIntyre, G.A. Zimmerman, R.L. White, and S.M. Prescott Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: evidence for a transcriptional effect Proc. Natl. Acad. Sci. U. S. A. 93 1996 4816 4820
180. H. Sano, Y. Kawahito, R.L. Wilder, A. Hashiramoto, S. Mukai, K. Asai, S. Kimura, H. Kato, M. Kondo, and T. Hla Expression of cyclooxygenase-1 and -2 in human colorectal cancer Cancer Res. 55 1995 3785 3789
181. C.E. Eberhart, R.J. Coffey, A. Radhika, F.M. Giardiello, S. Ferrenbach, and R.N. DuBois Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas Gastroenterology 107 1994 1183 1188
182. K. Subbaramaiah, N. Telang, J.T. Ramonetti, R. Araki, B. DeVito, B.B. Weksler, and A.J. Dannenberg Transcription of cyclooxygenase-2 is enhanced in transformed mammary epithelial cells Cancer Res. 56 1996 4424 4429
183. D. Hwang, D. Scollard, J. Byrne, and E. Levine Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer J. Natl. Cancer Inst. 90 1998 455 460
184. T. Hida, Y. Yatabe, H. Achiwa, H. Muramatsu, K. Kozaki, S. Nakamura, M. Ogawa, T. Mitsudomi, T. Sugiura, and T. Takahashi Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas Cancer Res. 58 1998 3761 3764
185. H. Wolff, K. Saukkonen, S. Anttila, A. Karjalainen, H. Vainio, and A. Ristimaki Expression of cyclooxygenase-2 in human lung carcinoma Cancer Res. 58 1998 4997 5001
186. B.P. van Rees, K. Saukkonen, A. Ristimaki, W. Polkowski, G.N. Tytgat, P. Drillenburg, and G.J. Offerhaus Cyclooxygenase-2 expression during carcinogenesis in the human stomach J. Pathol. 2002 196
187. A. Ristimaki, N. Honkanen, H. Jankala, P. Sipponen, and M. Harkonen Expression of cyclooxygenase-2 in human gastric carcinoma Cancer Res. 57 1997 1276 1280
188. J.R. Mestre, G. Chan, F. Zhang, E.K. Yang, P.G. Sacks, J.O. Boyle, J.P. Shah, D. Edelstein, K. Subbaramaiah, and A.J. Dannenberg Inhibition of cyclooxygenase-2 expression. An approach to preventing head and neck cancer Ann. N Y Acad. Sci. 889 1999 62 71
189. O. Gallo, A. Franchi, L. Magnelli, I. Sardi, A. Vannacci, V. Boddi, V. Chiarugi, and E. Masini Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer. Implications for tumor angiogenesis and metastasis Neoplasia 3 2001 53 61
190. G. Chan, J.O. Boyle, E.K. Yang, F. Zhang, P.G. Sacks, J.P. Shah, D. Edelstein, R.A. Soslow, A.T. Koki, B.M. Woerner, J.L. Masferrer, and A.J. Dannenberg Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck Cancer Res. 59 1999 991 994
191. O.N. Tucker, A.J. Dannenberg, E.K. Yang, F. Zhang, L. Teng, J.M. Daly, R.A. Soslow, J.L. Masferrer, B.M. Woerner, A.T. Koki, and T.J. Fahey 3rd Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer Cancer Res. 59 1999 987 990
192. B.J. Tong, J. Tan, L. Tajeda, S.K. Das, J.A. Chapman, R.N. DuBois, and S.K. Dey Heightened expression of cyclooxygenase-2 and peroxisome proliferator-activated receptor-delta in human endometrial adenocarcinoma Neoplasia 2 2000 483 490
193. D.K. Gaffney, J. Holden, M. Davis, K. Zempolich, K.J. Murphy, and M. Dodson Elevated cyclooxygenase-2 expression correlates with diminished survival in carcinoma of the cervix treated with radiotherapy Int. J. Radiat. Oncol. Biol. Phys. 49 2001 1213 1217
194. C.J. Grubbs, R.A. Lubet, A.T. Koki, K.M. Leahy, J.L. Masferrer, V.E. Steele, G.J. Kelloff, D.L. Hill, and K. Seibert Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitro amine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats Cancer Res. 60 2000 5599 5602
195. E.M. Grossman, W.E. Longo, N. Panesar, J.E. Mazuski, and D.L. Kaminski The role of cyclooxygenase enzymes in the growth of human gall bladder cancer cells Carcinogenesis 21 2000 1403 1409
196. S.Y. Buckman, A. Gresham, P. Hale, G. Hruza, J. Anast, J. Masferrer, and A.P. Pentland COX-2 expression is induced by UVB exposure in human skin: implications for the development of skin cancer Carcinogenesis 19 1998 723 729
197. K.P. An, M. Athar, X. Tang, S.K. Katiyar, J. Russo, J. Beech, M. Aszterbaum, L. Kopelovich, E.H. Epstein Jr., H. Mukhtar, and D.R. Bickers Cyclooxygenase-2 expression in murine and human non-melanoma skin cancers: implications for therapeutic approaches Photochem. Photobiol. 76 2002 73 80
198. M. Athar, K.P. An, K.D. Morel, A.L. Kim, M. Aszterbaum, J. Longley, E.H. Epstein Jr., and D.R. Bickers Ultraviolet B(UVB)-induced cox-2 expression in murine skin: an immunohistochemical study Biochem. Biophys. Res. Commun. 280 2001 1042 1047
199. C. Denkert, M. Kobel, S. Berger, A. Siegert, A. Leclere, U. Trefzer, and S. Hauptmann Expression of cyclooxygenase 2 in human malignant melanoma Cancer Res. 61 2001 303 308
200. J.L. Lee, H. Mukhtar, D.R. Bickers, L. Kopelovich, and M. Athar Cyclooxygenases in the skin: pharmacological and toxicological implications Toxicol. Appl. Pharmacol. 192 2003 294 306
201. H.F. Tiano, C.D. Loftin, J. Akunda, C.A. Lee, J. Spalding, A. Sessoms, D.B. Dunson, E.G. Rogan, S.G. Morham, R.C. Smart, and R. Langenbach Deficiency of either cyclooxygenase (COX)-1 or COX-2 alters epidermal differentiation and reduces mouse skin tumorigenesis Cancer Res. 62 2002 3395 3401
202. D.K. Bol, R.B. Rowley, C.P. Ho, B. Pilz, J. Dell, M. Swerdel, K. Kiguchi, S. Muga, R. Klein, and S.M. Fischer Cyclooxygenase-2 overexpression in the skin of transgenic mice results in suppression of tumor development Cancer Res. 62 2002 2516 2521
203. Y.J. Surh, K.S. Chun, H.H. Cha, S.S. Han, Y.S. Keum, K.K. Park, and S.S. Lee Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation Mut. Res. 480-481 2001 243 268
204. S.H. Tsai, Y.C. Liang, L. Chen, F.M. Ho, M.S. Hsieh, and J.K. Lin Arsenite stimulates cyclooxygenase-2 expression through activating IkappaB kinase and nuclear factor kappaB in primary and ECV304 endothelial cells J. Cell Biochem. 84 2002 750 758
205. S.R. Adderley, and D.J. Fitzgerald Oxidative damage of cardiomyocytes is limited by extracellular regulated kinases 1/2-mediated induction of cyclooxygenase-2 J. Biol. Chem. 274 1999 5038 5046
206. H.Q. Wang, M.P. Kim, H.F. Tiano, R. Langenbach, and R.C. Smart Protein kinase C-alpha coordinately regulates cytosolic phospholipase A(2) activity and the expression of cyclooxygenase-2 through different mechanisms in mouse keratinocytes Mol. Pharmacol. 59 2001 860 866
207. W. Xie, and H.R. Herschman v-src induces prostaglandin synthase 2 gene expression by activation of the c-Jun N-terminal kinase and the c-Jun transcription factor J. Biol. Chem. 270 1995 27622 27628
208. H. Niiro, T. Otsuka, E. Ogami, K. Yamaoka, S. Nagano, M. Akahoshi, H. Nakashima, Y. Arinobu, K. Izuhara, and Y. Niho MAP kinase pathways as a route for regulatory mechanisms of IL-10 and IL-4 which inhibit COX-2 expression in human monocytes Biochem. Biophys. Res. Commun. 250 1998 200 205
209. B.D. Jaffee, E.J. Manos, R.J. Collins, P.M. Czerniak, M.F. Favata, R.L. Magolda, P.A. Scherle, and J.M. Trzaskos Inhibition of MAP kinase kinase (MEK) results in an anti-inflammatory response in vivo Biochem. Biophys. Res. Commun. 268 2000 647 651
210. Z. Guan, S.Y. Buckman, B.W. Miller, L.D. SpriLnger, and A.R. Morrison Interleukin-1beta-induced cyclooxygenase-2 expression requires activation of both c-Jun NH2-terminal kinase and p38 MAPK signal pathways in rat renal mesangial cells J. Biol. Chem. 273 1998 28670 28676
211. M. Jang, L. Cai, G.O. Udeani, K.V. Slowing, C.F. Thomas, C.W. Beecher, H.H. Fong, N.R. Farnsworth, A.D. Kinghorn, R.G. Mehta, R.C. Moon, and J.M. Pezzuto Cancer chemopreventive activity of resveratrol, a natural product derived from grapes Science 275 1997 218 220
212. Z.G. Li, T. Hong, Y. Shimada, I. Komoto, A. Kawabe, Y. Ding, J. Kaganoi, Y. Hashimoto, and M. Imamura Suppression of N-nitrosomethylbenzylamine (NMBA)-induced esophageal tumorigenesis in F344 rats by resveratrol Carcinogenesis 23 2002 1531 1536
213. S. Banerjee, C. Bueso-Ramos, and B.B. Aggarwal Suppression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in rats by resveratrol: role of nuclear factor-kappaB, cyclooxygenase 2, and matrix metalloprotease 9 Cancer Res. 2002 62
214. K. Bove, D.W. Lincoln, and M.F. Tsan Effect of resveratrol on growth of 4T1 breast cancer cells in vitro and in vivo Biochem. Biophys. Res. Commun. 291 2002 1001 1005
215. K. Subbaramaiah, W.J. Chung, P. Michaluart, N. Telang, T. Tanabe, H. Inoue, M. Jang, J.M. Pezzuto, and A.J. Dannenberg Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells J. Biol. Chem. 273 1998 21875 21882
216. J. Garcia-Garcia, V. Micol, A. de Godos, and J.C. Gomez-Fernandez The cancer chemopreventive agent resveratrol is incorporated into model membranes and inhibits protein kinase C alpha activity Arch. Biochem. Biophys. 372 1999 382 388
217. S.J. Lee, I.S. Lee, and W. Mar Inhibition of inducible nitric oxide synthase and cyclooxygenase-2 activity by 1,2,3,4,6-penta-O-galloyl-beta-d- glucose in murine macrophage cells Arch. Pharm. Res. 26 2003 832 839
218. J.W. Park, Y.J. Choi, S.I. Suh, and T.K. Kwon Involvement of ERK and protein tyrosine phosphatase signaling pathways in EGCG-induced cyclooxygenase-2 expression in Raw 264.7 cells Biochem. Biophys. Res. Commun. 286 2001 721 725
219. Z.G. Li, Y. Shimada, F. Sato, M. Maeda, A. Itami, J. Kaganoi, I. Komoto, A. Kawabe, and M. Imamura Inhibitory effects of epigallocatechin-3-gallate on N-nitrosomethylbenzylamine-induced esophageal tumorigenesis in F344 rats Int. J. Oncol. 21 2002 1275 1283
220. J.K. Kundu, H.K. Na, K.S. Chun, Y.K. Kim, S.J. Lee, S.S. Lee, O.S. Lee, Y.C. Sim, and Y.J. Surh Inhibition of phorbol ester-induced COX-2 expression by epigallocatechin gallate in mouse skin and cultured human mammary epithelial cells J. Nutr. 133 2003 3805S 3810S
221. K.L. Koo, A.J. Ammit, V.H. Tran, C.C. Duke, and B.D. Roufogalis Gingerols and related analogues inhibit arachidonic acid-induced human platelet serotonin release and aggregation Thromb. Res. 103 2001 387 397
222. E. Tjendraputra, V.H. Tran, D. Liu-Brennan, B.D. Roufogalis, and C.C. Duke Effect of ginger constituents and synthetic analogues on cyclooxygenase-2 enzyme in intact cells Bioorg. Chem. 29 2001 156 163